Anya Revah-Politi, MS, CGC

  • Assistant Professor of Genetic Counseling
Profile Headshot


Anya Revah-Politi, MS, CGC is an Assistant Professor in Genetic Counseling in the Department of Neurology at Columbia University Irving Medical Center (CUIMC). Her role includes recruiting patients with neurogenetic disorders into the Precision Neurotherapeutics Program.

Anya is originally from Mexico City and completed her Genetic Counseling graduate education at Boston University. She is an ABGC board-certified genetic counselor with over 16 years of experience in clinical and laboratory genetic counseling, as well as academic research. After working as a prenatal and pediatric genetic counselor for seven years, she joined CUIMC in 2015 as a research genetic counselor at the Institute for Genomic Medicine (IGM). In 2018, she took an additional role as clinical laboratory genetic counselor at the Precision Genomics Laboratory (PGL). As of 2023, she joined the Department of Neurology as part of a new Precision Neurotherapeutics Program. The goal of this program is to identify patients with neurogenetic conditions who have mutations that are amenable potential genetic therapy development.

Anya brings a wealth of expertise and dedication to her work, contributing significantly to the fields of genetic counseling and neurogenetics. She is trilingual in English, Spanish, and French.

Academic Appointments

  • Assistant Professor of Genetic Counseling


  • English
  • French
  • Spanish


  • Female

Credentials & Experience

Education & Training

  • BS, 2004 Biology, Brandeis University
  • MS, 2007 Genetic Counseling, Boston University


During her eight years at the Institute for Genomic Medicine (IGM), Anya served as Lead Genetic Counselor and project manager for the Diagnostic Sequencing Study of Genetic Disorders, a research exome sequencing study aiming at identifying causative genomic variants in individuals with suspected genetic disease. In this role, she managed a team that enrolled over 1,500 families. Anya's responsibilities included developing an analysis strategy, variant interpretation, moderating result sign-out meetings for presentation of research result findings to healthcare providers, and coordinating confirmation of variants in the CLIA space. Through this work, she drove the team’s gene discovery and publication efforts, and participated in 15 publications describing new gene-disease associations, phenotype expansions, and novel disease mechanisms. Notably, her work on the GNB1 gene variants led to the publication of the GeneReview chapter for GNB1 Encephalopathy, where she served as the first author.

Additionally, Anya made substantial contributions to various other projects at the IGM, including The Genetics of Neurological, Neuropsychiatric and Neurodevelopmental Disorders Project, The Epilepsy Genetics Initiative, and other projects focused on identifying causal genomic variants in stillbirth, cerebral palsy, pregnancy and lactation-associated osteoporosis (PLO) and obsessive-compulsive disorder.

In her current role in the Department of Neurology, Anya is responsible for identifying patients with neurogenetic conditions who have genetic variants that are amenable to potential genetic therapy development. Patients with eligible genotypes and phenotypes can then be recruited into the Precision Neurotherapeutics Program, where Anya and the other members of the Precision Neurotherapeutics team work with therapeutic development partners to create N-of-1 therapies for individual patients.